Leukemic spleen cells are more potent than bone marrow-derived cells in a transgenic mouse model of CML
Year: 2011
Type: article
Source: Leukemia
DOI: 10.1038/leu.2011.366
Authors: M Schemionek, T Spieker, L Kerstiens, C Elling, M Essers, A Trumpp, W E Berdel, C Müller-Tidow, S Koschmieder
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Deutsche Forschungsgemeinschaft
OpenAlex ID: W2065358490
